Create accountLogin

Recent searches

No recent searches

Search options

Not available on mstdn.science.
mstdn.science is one of the many independent Mastodon servers you can use to participate in the fediverse.
http://mstdn.science is a place for scientists and science enthusiasts to discuss research and topics surrounding our work.

Administered by:

Server stats:

559
active users

mstdn.science: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.8

Jeff Gilchrist

Novavax found that antibody levels were lower but similar to those induced by the bivalent mRNA vaccines and those levels were likely associated with continued protection against severe outcomes.

Novavax expects to update its vaccine composition to restore cross-reactivity for future variants. 4/

Feb 04, 2023, 03:28 PM·Quiet public·Web
4boosts·3favorites
ExploreLive feeds
About